Liver Metastasis Recruiting Phase 4 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02380131Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver MetastasisTreatment